Publications by authors named "Ellen Lathi"

Claim this Profile
A
A Real-World Prospective Multiple Sclerosis Pregnancy Registry in the United States: PREG-MS.
Maria K Houtchens, Maria Claudia Manieri, Tatenda Dawn Mahlanza, Jeta Pol-Patil, Eric C Klawiter, Ellen Lathi

Neurol Clin Pract· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No Increase in Symptoms Toward the End of the Ocrelizumab Infusion Cycle in Patients With Multiple Sclerosis: Symptom Burden on Ocrelizumab: A Longitudinal Study (SymBOLS).
Ilya Kister, Cheongeun Oh, Elizabeth A Douglas, Tamar E Bacon, Isabella L O'Shea, Ellen Lathi

Neurol Clin Pract· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New England COVID-19 Registry of Patients With CNS Demyelinating Disease: A Pilot Analysis.
Kelli M Money, Ashmanie Mahatoo, Soleil Samaan, Pria Anand, Ursela Baber, Ellen Lathi

Neurol Neuroimmunol Neuroinflamm· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective growth and developmental outcomes in infants born to mothers with multiple sclerosis.
Tatenda Dawn Mahlanza, Maria Claudia Manieri, Eric C Klawiter, Andrew J Solomon, Ellen Lathi

Mult Scler· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leptomeningeal Enhancement on 3D-FLAIR MRI in Multiple Sclerosis: Systematic Observations in Clinical Practice.
David S Titelbaum, Renate Engisch, Eric D Schwartz, Salvatore Q Napoli, Jacob A Sloane, Ellen S Lathi

J Neuroimaging· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for cognitive screening and management in multiple sclerosis care.
Rosalind Kalb, Meghan Beier, Ralph Hb Benedict, Leigh Charvet, Kathleen Costello, Ellen Lathi

Mult Scler· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No evidence of disease activity in patients receiving fingolimod at private or academic centers in clinical practice: a retrospective analysis of the multiple sclerosis, clinical, and magnetic resonance imaging outcomes in the USA (MS-MRIUS) study.
Robert Zivadinov, Nasreen Khan, Jonathan R Korn, Ellen Lathi, Jason Silversteen

Curr Med Res Opin· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of alternative dose fingolimod for multiple sclerosis.
Erin E Longbrake, Daniel Kantor, Siddharama Pawate, Michael J Bradshaw, Gloria von Geldern, Ellen Lathi

Neurol Clin Pract· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing 'No Evidence of Disease Activity' Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study.
Bianca Weinstock-Guttman, Jennie Medin, Nasreen Khan, Jonathan R Korn, Ellen Lathi

CNS Drugs· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of disease-modifying therapies for MS: maximizing adherence and minimizing adverse events.
David W Brandes, Teri Callender, Ellen Lathi, Shirley O'Leary

Curr Med Res Opin· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis